Results 21 to 30 of about 137,708 (50)

Reproduction numbers of infectious disease models

Infectious Disease Modelling, 2017
This primer article focuses on the basic reproduction number, ℛ0, for infectious diseases, and other reproduction numbers related to ℛ0 that are useful in guiding control strategies.
Pauline van den Driessche
doaj   +1 more source

Predictive modelling of COVID-19 confirmed cases in Nigeria

Infectious Disease Modelling, 2020
The coronavirus outbreak is the most notable world crisis since the Second World War. The pandemic that originated from Wuhan, China in late 2019 has affected all the nations of the world and triggered a global economic crisis whose impact will be felt ...
Roseline O. Ogundokun, Adewale F. Lukman, Golam B.M. Kibria, Joseph B. Awotunde, Benedita B. Aladeitan   +4 more
doaj   +1 more source

Evaluation of Insect Growth Regulators (IGRs) as biological pesticides for control of Aedes aegypti mosquitoes

Journal of Vector Borne Diseases
Background & objectives: Insect growth regulators (IGRs) are biological hormone analogue or mimics used as pesticides to inhibit the growth of larva during their molting and skin shedding.
Adnan Ur Rahman, Inamullah Khan, Amjad Usman, Hasnain Khan   +3 more
doaj   +1 more source

Entomological assessment in ‘hotspots’ of four lymphatic filariasis endemic districts, Central Nepal during post-MDA surveillance

Journal of Vector Borne Diseases
Background & objectives: Annual mass drug administration (MDA) is the main strategy to interrupt the transmission of lymphatic filariasis (LF) in the community.
Pramod Kumar Mehta, Mahendra Maharjan
doaj   +1 more source

Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: A population-based, retrospective cohort study

International Journal of Infectious Diseases
Objectives: We aimed to compare the risk of herpes zoster (HZ) in adults with and without laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Elisa Correcher-Martínez, Mónica López-Lacort, Cintia Muñoz-Quiles, Javier Díez-Domingo, Alejandro Orrico-Sánchez   +4 more
doaj   +1 more source

Invasive fungal infections in patients with multiple myeloma: a possible growing problem in hematology and infectious diseases

Therapeutic Advances in Infectious Disease
Multiple myeloma is among the most common hematological malignancies and is characterized by a strong susceptibility to infections primarily bacterial and viral and, to a much lesser extent, fungal.
Toni Valkovic, Lucija Marcelic, Frane Valkovic   +2 more
doaj   +1 more source

Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay

BMC Infectious Diseases
Background Opportunistic infections (OIs) are common causes of mortality among people living with HIV (PLHIV). We determined prevalence and 30-day mortality due to histoplasmosis, cryptococcosis, and TB in PLHIV with advanced HIV disease (AHD).
Gloria Aguilar, Gladys Lopez, Omar Sued, Narda Medina, Diego H. Caceres, Jose Pereira, Alexander Jordan, Virgilio Lezcano, Cristina Vicenti, Gustavo Benitez, Tania Samudio, Freddy Perez   +11 more
doaj   +1 more source

Early predictors of delayed radiographic resolution of lobar pneumonia caused by Mycoplasma pneumoniae in children: a retrospective study in China

BMC Infectious Diseases
Background Lobar pneumonia caused by Mycoplasma pneumoniae is a relatively difficult-to-treat pneumonia in children. The time of radiographic resolution after treatment is variable, a long recovery time can result in several negative effects, and it has ...
Yu Zheng, Guoshun Mao, Hongchen Dai, Guitao Li, Liying Liu, Xiaying Chen, Ying Zhu   +6 more
doaj   +1 more source

Effect of concurrent infection of Helicobacter pylori with Toxoplasma gondii infection on gastric pathology

BMC Infectious Diseases
Background Toxoplasma gondii (T. gondii) and Helicobacter pylori (H. pylori) are among the most prevalent foodborne parasitic and bacterial infections worldwide.
Marwa A. Gouda, Sara A. Saied, Ahmed Edrees, Rasha Galal Mostafa, Ashraf Elfert, Aya Abdallah seleem, Asmaa Shams, Sameh Afify   +7 more
doaj   +1 more source

Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial

BMC Infectious Diseases
Considering that neutralizing antibody levels induced by two doses of the inactivated vaccine decreased over time and had fallen to low levels by 6 months, and homologous and heterologous booster immunization programs have been implemented in adults in ...
Tao Huang, Qianqian Hu, Xiang Zhou, Huaiyu Yang, Wei Xia, Feng Cao, Minglu Deng, Xiaoxue Teng, Fan Ding, Zaixin Zhong, Lidong Gao, Jiufeng Sun, Lihui Gong   +12 more
doaj   +1 more source